Skip to main content
Have a personal or library account? Click to login
Global Lipid Guidelines: More Aligned Than They Appear Cover

Global Lipid Guidelines: More Aligned Than They Appear

Open Access
|May 2026

References

  1. Mach F, Koskinas KC, Roeters Van Lennep JE, et al. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2025;46(42):43594378. DOI: 10.1093/eurheartj/ehaf190
  2. Puri R, Bansal M, Mehta V, et al. Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV. J Clin Lipidol. 2024;18(3):e351e373. DOI: 10.1016/j.jacl.2024.01.006
  3. Banach M, Reiner Ž, Surma S, et al. 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP). Drugs. 2024;84(12):15411577. DOI: 10.1007/s40265-024-02105-5
  4. Banach M, Toth PP, Ahn HJ, Bielecka-Dabrowa A, Cicero AFG, Covic A, et al. Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP). Prog Cardiovasc Dis. 2026 Jan–Feb;94:78110. DOI: 10.1016/j.pcad.2025.11.003
  5. Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. JACC. Published online March 2026:S0735109725102544. DOI: 10.1016/j.jacc.2025.11.016
  6. Lee YJ, Lee SJ, Kim JW, et al. Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease. N Engl J Med. Published online March 28, 2026. DOI: 10.1056/NEJMoa2600283
  7. Pradhan A, Thandi P, Mahajan K, Iellamo F, Perrone-Filardi P, Perrone MA. 2025 ESC/EAS Dyslipidemia Guidelines Focused Update: Intensifying Prevention, Risk Stratification, and Therapy. Am J Cardiol. Published online March 3, 2026:S0002-9149(26)00109-8. DOI: 10.1016/j.amjcard.2026.02.059
  8. Mahajan K, Jena S, Dutta D, et al. Efficacy and Safety of Upfront Oral Triple Lipid-Lowering Therapy: A Systematic Review and Single-Arm Meta-Analysis. Diabetes Obes Metab. Published online March 16, 2026. DOI: 10.1111/dom.70663
DOI: https://doi.org/10.5334/gh.1559 | Journal eISSN: 2211-8179
Language: English
Page range: 41 - 41
Submitted on: Apr 29, 2026
Accepted on: May 7, 2026
Published on: May 20, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Yashendra Sethi, Kunal Mahajan, Maciej Banach, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.